Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 0.8500
-0.0330 (-3.74%)
Oct 13, 2026, 3:13 PM CET
Intervacc AB Earnings Call Transcripts
Fiscal Year 2026
-
Breakthrough vaccines for horses and pigs are driving growth, with Strangvac showing high efficacy and safety, and U.S. market entry expected to be a major catalyst. PiggyBac addresses a large unmet need, and label changes plus new launches in Europe and beyond are set to boost adoption.